Needle-free vaccine delivery

被引：54

作者：

Kersten, Gideon ^{[1
]}

Hirschberg, Hoang ^{[1
]}

机构：

[1] Head Netherlands Vaccine Inst, Dept Res & Dev, NL-3720 AI Bilthoven, Netherlands

来源：

EXPERT OPINION ON DRUG DELIVERY | 2007年 / 4卷 / 05期

关键词：

adjuvants; dermal vaccination; jet injection; mucosal vaccination; needle free; vaccine;

D O I：

10.1517/17425247.4.5.459

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The need for minimally invasive delivery methods is urgent. As the number of registered vaccines increases, so does the number of injections. The use of sharps can be unsafe and needle immunisation is less suitable for mass immunisations during emergencies such as pandemics or bioterrorist attacks. The approach of combining vaccines has limitations due to high development costs, risk of pharmaceutical or immunological interference and economic risks. Advancements in the development of alternatives to injection with syringes and needles are discussed in this paper, and include: mucosal vaccination, injection without needles and vaccine delivery via the skin.

引用

页码：459 / 474

页数：16

共 140 条

[101] Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen a fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice [J].

Pimenta, F. C. ;

Miyaji, E. N. ;

Areas, A. P. M. ;

Oliveira, M. L. S. ;

de Andrade, A. L. S. S. ;

Ho, P. L. ;

Hollingshead, S. K. ;

Leite, L. C. C. .

INFECTION AND IMMUNITY, 2006, 74 (08) :4939-4944

[102] Microneedles for transdermal drug delivery [J].

Prausnitz, MR .

ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (05) :581-587

[103] Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age:: Dosing studies in different age groups [J].

Qadri, F ;

Ahmed, T ;

Ahmed, F ;

Begum, YA ;

Sack, DA ;

Svennerholm, AM .

VACCINE, 2006, 24 (10) :1726-1733

[104] Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations [J].

Ramasamy, R. ;

Yasawardena, S. ;

Zomer, A. ;

Venema, G. ;

Kok, J. ;

Leenhouts, K. .

VACCINE, 2006, 24 (18) :3900-3908

[105] Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route [J].

Ravichandran, Easwaran ;

Al-Saleem, Fetweh H. ;

Ancharski, Denise M. ;

Elias, Mohammad D. ;

Singh, Ajay K. ;

Shamim, Mohammad ;

Gong, Yujing ;

Simpson, Lance L. .

INFECTION AND IMMUNITY, 2007, 75 (06) :3043-3054

[106] Perspectives on polio and immunization in Northern Nigeria [J].

Renne, Elisha .

SOCIAL SCIENCE & MEDICINE, 2006, 63 (07) :1857-1869

[107] The Mycoplasma-derived macrophage-activating 2-kilodalton lipopeptide triggers global immune activation on nasal mucosa-associated lymphoid tissues [J].

Rharbaoui, F ;

Westendorf, A ;

Link, C ;

Felk, S ;

Buer, J ;

Gunzer, M ;

Guzmán, CA .

INFECTION AND IMMUNITY, 2004, 72 (12) :6978-6986

[108] Active induction of tumor-specific IgE antibodies by oral mimotope vaccination [J].

Riemer, Angelika B. ;

Untersmayr, Eva ;

Knittelfelder, Regina ;

Duschl, Albert ;

Pehamberger, Hubert ;

Zielinski, Christoph C. ;

Scheiner, Otto ;

Jensen-Jarolim, Erika .

CANCER RESEARCH, 2007, 67 (07) :3406-3411

[109] Live attenuated oral cholera vaccines [J].

Ryan, Edward T. ;

Calderwood, Stephen B. ;

Qadri, Firdausi .

EXPERT REVIEW OF VACCINES, 2006, 5 (04) :483-494

[110] Use of an oral diphtheria vaccine in human [J].

Rydell, Niclas ;

Stertman, Linda ;

Stalenheim, Gunnernar ;

Sjoholm, Ingvar .

VACCINE, 2006, 24 (33-34) :5928-5930

← 5 6 7 8 9 10 11 12 13 14 →